Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
DNA Ginkgo Bioworks Holdings, Inc.
How to master the process that’s transforming management by Darrell Rigby, Jeff Sutherland and Hirotaka Takeuchi Agile innovation methods have revolutionized information technology. Over the past 25 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results